Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Otolaryngology
Volume 2016, Article ID 2868190, 5 pages
http://dx.doi.org/10.1155/2016/2868190
Case Report

Bilateral Vocal Cord Paralysis and Cervicolumbar Radiculopathy as the Presenting Paraneoplastic Manifestations of Small Cell Lung Cancer: A Case Report and Literature Review

1Department of Otolaryngology-Head & Neck Surgery, University of Ottawa, Ottawa, ON, Canada
2Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
3Department of Pathology & Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada

Received 20 May 2016; Revised 7 August 2016; Accepted 17 August 2016

Academic Editor: Tamás Karosi

Copyright © 2016 Jeffrey C. Yeung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. D. Holinger, P. C. Holinger, and P. H. Holinger, “Etiology of bilateral abductor vocal cord paralysis: a review of 389 cases,” Annals of Otology, Rhinology and Laryngology, vol. 85, no. 4 I, pp. 428–436, 1976. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Y. Chang, T. Martinu, and D. L. Witsell, “Bilateral vocal cord paresis as a presenting sign of paraneoplastic syndrome: case report,” Otolaryngology-Head and Neck Surgery, vol. 130, no. 6, pp. 788–790, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Martinu and A. S. Clay, “A 50-year-old woman with bilateral vocal cord paralysis and hilar mass,” Chest, vol. 128, no. 2, pp. 1028–1031, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Graus and J. Dalmau, “Paraneoplastic neuropathies,” Current Opinion in Neurology, vol. 26, no. 5, pp. 489–495, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Graus, F. Keime-Guibert, R. Reñe et al., “Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients,” Brain, vol. 124, no. 6, pp. 1138–1148, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Senties-Madrid and F. Vega-Boada, “Paraneoplastic syndromes associated with anti-Hu antibodies,” The Israel Medical Association Journal, vol. 3, no. 2, pp. 94–103, 2001. View at Google Scholar · View at Scopus
  7. F. Graus, C. Cordon-Cardo, and J. B. Posner, “Neuronal antinuclear antibody in sensory neuronopathy from lung cancer,” Neurology, vol. 35, no. 4, pp. 538–543, 1985. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Grisold and M. Drlicek, “Paraneoplastic neuropathy,” Current Opinion in Neurology, vol. 12, no. 5, pp. 617–625, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Tsou, M. Kazarian, A. Patel et al., “Low level anti-Hu reactivity: a risk marker for small cell lung cancer?” Cancer Detection and Prevention, vol. 32, no. 4, pp. 292–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Hoosien, J. Vredenburgh, J. Lanfranco et al., “A myxoid chondrosarcoma associated with an anti-Hu-positive paraneoplastic encephalomyelitis,” Journal of Neuro-Oncology, vol. 101, no. 1, pp. 135–139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Lukacs, N. Szabo, and S. Woodhams, “Rare association of anti-hu antibody positive paraneoplastic neurological syndrome and transitional cell bladder carcinoma,” Case Reports in Urology, vol. 2012, Article ID 724940, 3 pages, 2012. View at Publisher · View at Google Scholar
  12. J. K. Jakobsen, E. R. Zakharia, A. K. Boysen, H. Andersen, F. E. Schlesinger, and L. Lund, “Prostate cancer may trigger paraneoplastic limbic encephalitis: a case report and a review of the literature,” International Journal of Urology, vol. 20, no. 7, pp. 734–737, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Kalanie, A. A. Harandi, M. Mardani et al., “Trigeminal neuralgia as the first clinical manifestation of anti-Hu paraneoplastic syndrome induced by a borderline ovarian mucinous tumor,” Case Reports in Neurology, vol. 6, no. 1, pp. 7–13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Pohley, K. Roesler, M. Wittstock, A. Bitsch, R. Benecke, and A. Wolters, “NMDA-receptor antibody and anti-Hu antibody positive paraneoplastic syndrome associated with a primary mediastinal seminoma,” Acta Neurologica Belgica, vol. 115, no. 1, pp. 81–83, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Honnorat, A. Didelot, E. Karantoni et al., “Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer,” Neurology, vol. 80, no. 24, pp. 2226–2232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. C. F. Lucchinetti, D. W. Kimmel, and V. A. Lennon, “Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies,” Neurology, vol. 50, no. 3, pp. 652–657, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Renna, D. Plantone, and A. P. Batocchi, “Teaching NeuroImages: a case of hearing loss in a paraneoplastic syndrome associated with anti-Hu antibody,” Neurology, vol. 79, no. 15, article e134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Keime-Guibert, F. Graus, A. Fleury et al., “Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone,” Journal of Neurology Neurosurgery and Psychiatry, vol. 68, no. 4, pp. 479–482, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Graus, J. Dalmau, R. Reñé et al., “Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival,” Journal of Clinical Oncology, vol. 15, no. 8, pp. 2866–2872, 1997. View at Google Scholar · View at Scopus
  20. E. Mawhinney, O. M. Gray, F. McVerry, and G. V. McDonnell, “Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma,” BMJ Case Reports, vol. 2010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Graus, J. Y. Delattre, J. C. Antoine et al., “Recommended diagnostic criteria for paraneoplastic neurological syndromes,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 75, no. 8, pp. 1135–1140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Giometto, R. Vitaliani, E. Lindeck-Pozza, W. Grisold, and C. Vedeler, “Treatment for paraneoplastic neuropathies,” Cochrane Database of Systematic Reviews, vol. 12, Article ID CD007625, 2012. View at Google Scholar · View at Scopus
  23. A. H. de Jongste, T. van Gelder, J. E. Bromberg et al., “A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes,” Neuro-Oncology, vol. 17, no. 1, pp. 145–150, 2015. View at Publisher · View at Google Scholar · View at Scopus